Streetbeat News

Analyst Ratings

AVBP

Goldman Sachs analyst Corinne Johnson initiates coverage on ArriVent BioPharma (NASDAQ:AVBP) with a Buy rating and a price target of $27.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 10:47 am

LULU

Needham analyst Anna Andreeva has reiterated a Buy rating on Lululemon Athletica (NASDAQ:LULU) and maintained a $525 price target.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 10:39 am

URBN

Telsey Advisory Group analyst Dana Telsey has reiterated an Outperform rating on Urban Outfitters (NASDAQ:URBN) and maintained a $44 price target.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 10:37 am

BTSG

Goldman Sachs has initiated coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and set a price target of $26.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 10:35 am

CGON

Goldman Sachs has initiated coverage on CG Oncology (NASDAQ:CGON) with a Neutral rating and set a price target of $42.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 10:33 am

MSDL

Keefe, Bruyette & Woods analyst Ryan Lynch initiates coverage on Morgan Stanley Direct (MSDL) with a Market Perform rating and a price target of $21.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 10:29 am

CGON

Morgan Stanley analyst Jeffrey Hung initiates coverage on CG Oncology (NASDAQ:CGON) with an Overweight rating and a price target of $55.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 10:27 am

NCDL

Keefe, Bruyette & Woods analyst Ryan Lynch initiates coverage on Nuveen Churchill Direct (NCDL) with a Market Perform rating and a price target of $18.5.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 10:24 am

GES

Telsey Advisory Group analyst Dana Telsey reiterated a 'Market Perform' rating on Guess (NYSE:GES) and maintained a $23 price target.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 10:12 am

GPMT

JMP Securities analyst Steven Delaney downgraded Granite Point Mortgage (GPMT) from Market Outperform to Market Perform, indicating a neutral outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 10:08 am